Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

AIMS: Interferon‐free direct‐acting antiviral agent (DAA) regimens for chronic hepatitis C virus (HCV) patients have improved their health‐related quality of life (HRQOL). Currently, there are no published data assessing the impact of DAAs regimens without sofosbuvir on HRQOL. The aim of this study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Ikeda, Hiroki, Watanabe, Tsunamasa, Matsumoto, Nobuyuki, Hiraishi, Tetsuya, Nakano, Hiroyasu, Noguchi, Yohei, Hattori, Nobuhiro, Shigefuku, Ryuta, Yamashita, Masaki, Nakahara, Kazunari, Matsunaga, Kotaro, Okuse, Chiaki, Yotsuyanagi, Hiroshi, Tanaka, Atsushi, Suzuki, Michihiro, Itoh, Fumio
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207024/
https://ncbi.nlm.nih.gov/pubmed/30483569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados